VIET LE: Open Payments
NPI 1669440152 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,877 in 58 payments from 15 companies in 2025. Trend: 2023 $1,007 · 2024 $20,182 · 2025 $19,877
Consulting: $7,670Speaker / faculty: $6,400Travel & lodging: $3,914Food & beverage: $1,880Education: $14
| Company | Payments | Amount |
|---|---|---|
| Amarin Pharma, Inc. | 11 | $8,720 |
| Merck Sharp & Dohme LLC | 11 | $3,944 |
| Esperion Therapeutics, Inc. | 7 | $2,261 |
| PFIZER INC. | 5 | $1,818 |
| Novo Nordisk Inc | 4 | $1,277 |
| Amgen Inc. | 7 | $914 |
| Novartis Pharmaceuticals Corporation | 3 | $399 |
| Corcept Therapeutics | 2 | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $116 |
| Analog Devices Inc. | 1 | $108 |
Products named: Vascepa, NEXLIZET, NURTEC ODT, REPATHA, LEQVIO, Korlym, NEXLETOL, Sensinel CPM Wearable.
Industry payments across UT — which companies pay providers there.
